HomeTLIS • OTCMKTS
add
Talis Biomedical Corp
Previous close
$1.79
Year range
$1.37 - $9.60
Market cap
3.26M USD
Avg Volume
3.78K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.98M | 24.45% |
Net income | -8.85M | 41.14% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.49M | 41.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.87M | -39.04% |
Total assets | 72.70M | -40.93% |
Total liabilities | 24.07M | -10.54% |
Total equity | 48.63M | — |
Shares outstanding | 1.82M | — |
Price to book | 0.07 | — |
Return on assets | -30.86% | — |
Return on capital | -33.41% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -8.85M | 41.14% |
Cash from operations | -11.33M | 20.62% |
Cash from investing | 84.00K | 117.32% |
Cash from financing | 0.00 | — |
Net change in cash | -11.25M | 23.80% |
Free cash flow | -9.31M | 24.41% |
About
Founded
2013
Headquarters
Website
Employees
99
